Assertio announced that Sravan Emany has been appointed to the Company’s Board of Directors. As part of the appointment, Assertio has expanded its board to seven seats. Emany currently serves as the Chief Financial Officer of Ironwood Pharmaceuticals.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ASRT:
- Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors
- Assertio Holdings price target lowered to $4 from $7 at Lake Street
- Assertio Holdings price target lowered to $3.50 from $7 at Roth MKM
- Assertio Holdings reports Q3 EPS 1c, consensus 11c
- Assertio Reports Third Quarter 2023 Financial Results
